Shield
STX.LShield Therapeutics plc Price (STX.L)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
722,544,000
(209.8521)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Shield Therapeutics plcCurrency: GBp
| YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
304,000.00
+0% |
637,000.00
+110% |
11,881,000.00
+1,765% |
719,000.00
-94% |
10,387,000.00
+1,345% |
1,519,000.00
-85% |
4,467,000.00
+194% |
13,085,000.00
+193% |
|||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 50,000.00 | 100,000.00 | 155,000.00 | 311,000.00 | 485,000.00 | 1,354,000.00 | 980,000.00 | 2,470,000.00 | 9,058,000.00 | |||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
-50,000.00
+0% |
204,000.00
-508% |
482,000.00
+136% |
11,570,000.00
+2,300% |
234,000.00
-98% |
9,033,000.00
+3,760% |
539,000.00
-94% |
1,997,000.00
+271% |
4,027,000.00
+102% |
|||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.67%) | (0.76%) | (0.97%) | (0.33%) | (0.87%) | (0.36%) | (0.45%) | (0.31%) | |||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 2,668,000.00 | 5,284,000.00 | 2,029,000.00 | 4,711,000.00 | 4,300,000.00 | 2,496,000.00 | 2,579,000.00 | 579,000.00 | 1,072,000.00 | 1,810,000.00 | |||||||||
| General and Administrative | 967,000.00 | 1,371,000.00 | 8,739,000.00 | 16,722,000.00 | 6,589,000.00 | 4,093,000.00 | 5,622,000.00 | 20,023,000.00 | 27,331,000.00 | 15,172,000.00 | |||||||||
| Selling, General & Admin... | 967,000.00 | 1,371,000.00 | 8,739,000.00 | 16,722,000.00 | 10,084,000.00 | 4,152,000.00 | 5,903,000.00 | 20,023,000.00 | 27,331,000.00 | 36,889,000.00 | |||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 4,174,000.00 | 9,133,000.00 | 3,495,000.00 | 59,000.00 | 281,000.00 | 10,262,000.00 | 16,008,000.00 | 21,717,000.00 | |||||||||
| Depreciation and Amortiz... | 36,000.00 | 50,000.00 | 1,936,000.00 | 2,437,000.00 | 2,690,000.00 | 2,621,000.00 | 2,705,000.00 | 2,207,000.00 | 2,362,000.00 | 1,071,000.00 | |||||||||
| Other Expenses | -244,000.00 | -221,000.00 | 1,896,000.00 | 2,437,000.00 | 2,354,000.00 | 2,621,000.00 | 2,705,000.00 | -111,000.00 | -700,000.00 | -3,341,000.00 | |||||||||
| Total Operating Expenses | 3,391,000.00 | 6,434,000.00 | 12,664,000.00 | 21,433,000.00 | 16,738,000.00 | 9,269,000.00 | 11,187,000.00 | 20,491,000.00 | 27,703,000.00 | 35,358,000.00 | |||||||||
| Cost and Exponses | 3,391,000.00 | 6,434,000.00 | 12,764,000.00 | 21,588,000.00 | 17,049,000.00 | 9,754,000.00 | 12,541,000.00 | 21,471,000.00 | 30,173,000.00 | 44,416,000.00 | |||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-3,391,000.00
+0% |
-6,434,000.00
+90% |
-12,460,000.00
+94% |
-20,951,000.00
+68% |
-5,168,000.00
-75% |
-9,035,000.00
+75% |
-1,886,000.00
-79% |
-19,952,000.00
+958% |
-25,706,000.00
+29% |
-31,331,000.00
+22% |
|||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (-40.99%) | (-32.89%) | (-0.43%) | (-12.57%) | (-0.18%) | (-13.13%) | (-5.75%) | (-2.39%) | |||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 0.00 | 58,000.00 | 15,000.00 | 50,000.00 | 18,000.00 | 3,000.00 | 395,000.00 | 721,000.00 | 518,000.00 | |||||||||
| Interest Expenses | 1,655,000.00 | 1,866,000.00 | 14,000.00 | 17,000.00 | 35,000.00 | 49,000.00 | 1,000.00 | 8,000.00 | 389,000.00 | 1,016,000.00 | |||||||||
| Total Other Income/Exp... | -10,039,000.00 | -18,054,000.00 | -3,143,000.00 | -43,000.00 | 15,000.00 | -31,000.00 | 0.00 | 387,000.00 | -23,637,000.00 | 5,286,230.00 | |||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -11,734,000.00 | -22,566,000.00 | -13,653,000.00 | -18,540,000.00 | -2,764,000.00 | -6,396,000.00 | 820,000.00 | -17,350,000.00 | -37,392,223.00 | -30,288,000.00 | |||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (-37.02%) | (-29.11%) | (-0.23%) | (-8.90%) | (0.08%) | (-11.42%) | (-5.06%) | (-2.31%) | |||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -13,430,000.00 | -24,488,000.00 | -15,603,000.00 | -20,994,000.00 | -5,153,000.00 | -9,066,000.00 | -1,886,000.00 | -19,565,000.00 | -40,082,000.00 | -26,044,770.00 | |||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (-51.33%) | (-32.96%) | (-0.43%) | (-12.61%) | (-0.18%) | (-12.88%) | (-8.97%) | (-1.99%) | |||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -525,000.00 | -861,000.00 | -587,000.00 | -1,406,000.00 | -3,359,000.00 | -266,000.00 | 744,000.00 | -229,000.00 | 362,000.00 | 918,000.00 | |||||||||
| Net Income | |||||||||||||||||||
| Net Income | -12,905,000.00
+0% |
-23,627,000.00
+83% |
-15,016,000.00
-36% |
-19,588,000.00
+30% |
-1,794,000.00
-91% |
-8,800,000.00
+391% |
-2,630,000.00
-70% |
-19,336,000.00
+635% |
-40,444,000.00
+109% |
-33,293,000.00
-18% |
|||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (-49.39%) | (-30.75%) | (-0.15%) | (-12.24%) | (-0.25%) | (-12.73%) | (-9.05%) | (-2.54%) | |||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.39 | -0.55 | -0.14 | -0.17 | -0.02 | -0.07 | -0.02 | -0.09 | -0.17 | -0.04 | |||||||||
| Diluted EPS | -0.39 | -0.55 | -0.14 | -0.17 | -0.02 | -0.07 | -0.02 | -0.09 | -0.17 | -0.04 | |||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 32,831,029.00 | 42,727,794.00 | 104,135,294.00 | 115,662,647.00 | 119,850,294.00 | 120,430,000.00 | 120,680,000.00 | 204,410,000.00 | 233,190,000.00 | 722,544,000.00 | |||||||||
| Diluted Share Outstanding | 32,831,029.00 | 42,727,794.00 | 104,135,294.00 | 115,662,647.00 | 119,850,294.00 | 120,430,000.00 | 120,680,000.00 | 204,410,000.00 | 233,190,000.00 | 722,544,000.00 | |||||||||